RMFCX
Price
$64.05
Change
+$0.03 (+0.05%)
Updated
Jul 31 closing price
Net Assets
118.05B
SLVIX
Price
$47.84
Change
+$0.24 (+0.50%)
Updated
Jul 31 closing price
Net Assets
3.15B
Interact to see
Advertisement

RMFCX vs SLVIX

RMFCX vs SLVIX Comparison Chart in %
View a ticker or compare two or three
VS
RMFCX vs. SLVIX commentary
Aug 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and SLVIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 118B vs. SLVIX (3.15B). SLVIX pays higher dividends than RMFCX: SLVIX (1.36) vs RMFCX (1.16). RMFCX was incepted earlier than SLVIX: RMFCX (24 years) vs SLVIX (25 years). RMFCX (0.91) is less costly to investors than SLVIX (0.73). RMFCX is a more actively managed with annual turnover of: 30.00 vs. SLVIX (28.00). SLVIX has a lower initial minimum investment than RMFCX: SLVIX (0) vs RMFCX (250). SLVIX annual gain was more profitable for investors over the last year : 28.63 vs. RMFCX (9.09). SLVIX return over 5 years is better than : 63.73 vs. RMFCX (37.08).
RMFCXSLVIXRMFCX / SLVIX
Total Expense Ratio0.910.53172%
Annual Report Gross Expense Ratio0.910.73125%
Fund Existence24 years25 years-
Gain YTD9.49616.79757%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets118B3.15B3,750%
Annual Yield % from dividends1.161.3685%
Returns for 1 year9.0928.6332%
Returns for 3 years33.1654.9060%
Returns for 5 years37.0863.7358%
Returns for 10 years92.36134.4969%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLPC368.46N/A
N/A
Preformed Line Products Company
DYORU10.15N/A
N/A
Insight Digital Partners II
CAE25.83N/A
N/A
CAE Inc
RCKT3.11-0.10
-3.12%
Rocket Pharmaceuticals
KPTI1.92-5.09
-72.61%
Karyopharm Therapeutics Inc.